Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Neuropharmacology|October 5, 2022
(2R,6R)-hydroxynorketamine (HNK) reverses mechanical hypersensitivity in a model of localized inflammatory painJonathan G Yost, Caroline A Browne, Irwin LuckiAdvances in Drug and Alcohol Research|September 30, 2022
Buprenorphine as a Treatment for Major Depression and Opioid Use DisorderAmanda B Namchuk, Irwin Lucki, Caroline A BrownePhysiology & Behavior|January 17, 2017
Hair corticosterone measurement in mouse models of type 1 and type 2 diabetes mellitusRebecca L Erickson, Caroline A Browne, Irwin LuckiBehavioural Brain Research|December 3, 2014
Antidepressant-like effects of buprenorphine in rats are strain dependentCaroline A Browne, Duncan S van Nest, Irwin LuckiNeuroscience and Biobehavioral Reviews|May 7, 2021
Translational relevance of fear conditioning in rodent models of mild traumatic brain injuryClaire Kostelnik, Irwin Lucki, Kwang H Choi, et al.Neuropharmacology|December 7, 2010
Differential stress-induced alterations in tryptophan hydroxylase activity and serotonin turnover in two inbred mouse strainsCaroline A Browne, Gerard Clarke, Timothy G Dinan, et al.Progress in Brain Research|October 14, 2018
Opioid modulation of cognitive impairment in depressionMoriah L Jacobson, Hildegard A Wulf, Caroline A Browne, et al.Pharmacology, Biochemistry, and Behavior|August 16, 2024
Kappa opioid receptor mediated operant performance in male and female ratsAmanda B Namchuk, Mumeko C Tsuda, Irwin Lucki, et al.The Journal of Pharmacology and Experimental Therapeutics|July 2, 2022
Antinociceptive and Analgesic Effects of (2R,6R)-HydroxynorketamineJonathan G Yost, Hildegard A Wulf, Caroline A Browne, et al.Psychopharmacology|September 7, 2020
The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male miceMoriah L Jacobson, Hildegard A Wulf, Caroline A Browne, et al.Pageof 4